Efficacy and Safety of Biosimilar QL1207 vs. the Reference Aflibercept for Patients with Neovascular Age-Related Macular Degeneration: A Randomized Phase 3 Trial
生物类似药QL1207与参考药物阿柏西普治疗新生血管性年龄相关性黄斑变性的疗效和安全性：一项随机3期试验
期刊:Ophthalmology and Therapy
影响因子:3.2
doi:10.1007/s40123-023-00836-4
Li, Bing; Fan, Ke; Zhang, Tonghe; Wu, Zhifeng; Zeng, Siming; Zhao, Mingwei; Ren, Qian; Zheng, Dongping; Wang, Lifei; Liu, Xiaoling; Han, Mei; Song, Yanping; Ye, Jian; Pei, Cheng; Yi, Jinglin; Wang, Xian; Peng, Hui; Zhang, Hong; Zhou, Zhanyu; Liang, Xiaoling; Yu, Fangliang; Wu, Miaoqin; Li, Chaopeng; Lei, Chunling; Hao, Jilong; Tang, Luosheng; Yuan, Huiping; Cai, Shanjun; Li, Qiuming; Zhong, Jingxiang; Li, Suyan; Liu, Lin; Ke, Min; Wang, Jing; Wang, Hui; Zhu, Mengli; Wang, Zenghua; Yan, Yang; Wang, Feng; Chen, Youxin
